aluates Reports

$ 0.0

Automative

Global and India Rivaroxaban Market Report & Forecast 2023-2029

Published Date: November 2023

Report Code: QYRE-Auto-28E15576

BUY CHAPTERS

Global and India Rivaroxaban Market Report & Forecast 2023-2029

Code: QYRE-Auto-28E15576

Report

November 2023

Pages:75

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bayer

Bayer AG

Janssen Pharmaceutica

J & J

and India Rivaroxaban Market Size

The global Rivaroxaban revenue was US$ 7995 million in 2022 and is forecast to a readjusted size of US$ 13970 million by 2029 with a CAGR of 8.2% during the forecast period (2023-2029).

and India Rivaroxaban Market

Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8–12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.

In India, the Rivaroxaban revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).

The major players in global Prom Dresses market include Bayer, Johnson and Johnson, etc. The top 2 players occupy nearly 100% of the market. Europe is the main market, and occupies nearly 100% of the global market. 10 mg is the main type, with a share over 30%. Venous Thromboembolism (VTE) is the main application, which holds a share about 85%.

This report focuses on global and India Rivaroxaban market, also covers the segmentation data of other regions in regional level and county level.

India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.

India is a market full of opportunities, and the demand for Rivaroxaban will continue to grow rapidly in the future.

Global Rivaroxaban Scope and Market Size

Rivaroxaban market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Rivaroxaban market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.

For India market, this report focuses on the Rivaroxaban market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Rivaroxaban Market Report

Report Metric	Details
Report Name	and India Rivaroxaban Market
Forecasted market size in 2029	US$ 13970 million
CAGR	8.2%
Forecasted years	2023 - 2029
Segment by Type	2.5 mg 10 mg 15 mg 20 mg
Segment by Application	Acute Coronary Syndrome (ACS) Venous Thromboembolism (VTE)
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer, J&J
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Rivaroxaban Market size in 2029?

Ans: The and India Rivaroxaban Market size in 2029 will be US$ 13970 million.

What is the market share of major companies in and India Rivaroxaban Market?

Ans: The top 2 players occupy nearly 100% of the market.

What is the and India Rivaroxaban Market share by region?

Ans: Europe is the main market, and occupies nearly 100% of the global market. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

What is the and India Rivaroxaban Market share by type?

Ans: 10 mg is the main type, with a share over 30%.

What is the and India Rivaroxaban Market share by application?

Ans: Venous Thromboembolism (VTE) is the main application, which holds a share about 85%.

Who are the main players in the and India Rivaroxaban Market report?

Ans: The main players in the and India Rivaroxaban Market are Bayer, J&J

What are the Application segmentation covered in the and India Rivaroxaban Market report?

Ans: The Applications covered in the and India Rivaroxaban Market report are Acute Coronary Syndrome (ACS), Venous Thromboembolism (VTE)

What are the Type segmentation covered in the and India Rivaroxaban Market report?

Ans: The Types covered in the and India Rivaroxaban Market report are 2.5 mg, 10 mg, 15 mg, 20 mg

Recommended Reports

Anticoagulant Drugs

Thrombosis & VTE

Cardiovacular Drugs

1 Study Coverage

1.1 Rivaroxaban Product Introduction

1.2 Global Rivaroxaban Outlook 2018 VS 2022 VS 2029

1.2.1 Global Rivaroxaban Sales in US$ Million for the Year 2018-2029

1.2.2 Global Rivaroxaban Sales in Volume for the Year 2018-2029

1.3 India Rivaroxaban Outlook 2018 VS 2022 VS 2029

1.3.1 India Rivaroxaban Sales in US$ Million for the Year 2018-2029

1.3.2 India Rivaroxaban Sales in Volume for the Year 2018-2029

1.4 Rivaroxaban Market Size, India VS Global, 2018 VS 2022 VS 2029

1.4.1 The Market Share of India Rivaroxaban in Global, 2018 VS 2022 VS 2029

1.4.2 The Growth Rate of Rivaroxaban Market Size, India VS Global, 2018 VS 2022 VS 2029

1.5 Rivaroxaban Market Dynamics

1.5.1 Rivaroxaban Industry Trends

1.5.2 Rivaroxaban Market Drivers

1.5.3 Rivaroxaban Market Challenges

1.5.4 Rivaroxaban Market Restraints

1.6 Study Objectives

1.7 Years Considered

1.8 Years Considered

2 Rivaroxaban by Type

2.1 Rivaroxaban Market Segment by Type

2.1.1 2.5 mg

2.1.2 10 mg

2.1.3 15 mg

2.1.4 20 mg

2.2 Global Rivaroxaban Market Size by Type

2.2.1 Global Rivaroxaban Sales in Value, by Type (2018, 2022 & 2029)

2.2.2 Global Rivaroxaban Sales in Volume, by Type (2018, 2022 & 2029)

2.2.3 Global Rivaroxaban Average Selling Price (ASP) by Type (2018, 2022 & 2029)

2.3 India Rivaroxaban Market Size by Type

2.3.1 India Rivaroxaban Sales in Value, by Type (2018, 2022 & 2029)

2.3.2 India Rivaroxaban Sales in Volume, by Type (2018, 2022 & 2029)

2.3.3 India Rivaroxaban Average Selling Price (ASP) by Type (2018, 2022 & 2029)

3 Rivaroxaban by Application

3.1 Rivaroxaban Market Segment by Application

3.1.1 Acute Coronary Syndrome (ACS)

3.1.2 Venous Thromboembolism (VTE)

3.2 Global Rivaroxaban Market Size by Application

3.2.1 Global Rivaroxaban Sales in Value, by Application (2018, 2022 & 2029)

3.2.2 Global Rivaroxaban Sales in Volume, by Application (2018, 2022 & 2029)

3.3.3 Global Rivaroxaban Average Selling Price (ASP) by Application (2018, 2022 & 2029)

3.3 India Rivaroxaban Market Size by Application

3.3.1 India Rivaroxaban Sales in Value, by Application (2018, 2022 & 2029)

3.3.2 India Rivaroxaban Sales in Volume, by Application (2018, 2022 & 2029)

3.3.3 India Rivaroxaban Average Selling Price (ASP) by Application (2018, 2022 & 2029)

4 Global Rivaroxaban Competitor Landscape by Company

4.1 Global Rivaroxaban Market Size by Company

4.1.1 Global Key Manufacturers of Rivaroxaban, Ranked by Revenue (2022)

4.1.2 Global Rivaroxaban Revenue by Manufacturer (2018-2023)

4.1.3 Global Rivaroxaban Sales by Manufacturer (2018-2023)

4.1.4 Global Rivaroxaban Price by Manufacturer (2018-2023)

4.2 Global Rivaroxaban Concentration Ratio (CR)

4.2.1 Rivaroxaban Market Concentration Ratio (CR)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Rivaroxaban in 2022

4.2.3 Global Rivaroxaban Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Key Manufacturers of Rivaroxaban, Manufacturing Base Distribution and Headquarters

4.4 Global Key Manufacturers of Rivaroxaban, Product Offered and Application

4.5 Global Key Manufacturers of Rivaroxaban, Date of Enter into This Industry

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.7 India Rivaroxaban Market Size by Company

4.7.1 Key Players of Rivaroxaban in India, Ranked by Revenue (2022)

4.7.2 India Rivaroxaban Revenue by Players (2018-2023)

4.7.3 India Rivaroxaban Sales by Players (2018-2023)

5 Global Rivaroxaban Market Size by Region

5.1 Global Rivaroxaban Market Size by Region: 2018 VS 2022 VS 2029

5.2 Global Rivaroxaban Market Size in Volume by Region (2018-2029)

5.2.1 Global Rivaroxaban Sales in Volume by Region: 2018-2023

5.2.2 Global Rivaroxaban Sales in Volume Forecast by Region (2024-2029)

5.3 Global Rivaroxaban Market Size in Value by Region (2018-2029)

5.3.1 Global Rivaroxaban Sales in Value by Region: 2018-2023

5.3.2 Global Rivaroxaban Sales in Value by Region: 2024-2029

6 Americas

6.1 Americas Rivaroxaban Market Size YoY Growth 2018-2029

6.2 Americas Rivaroxaban Sales in Volume, by Type (2018, 2022 & 2029)

6.3 Americas Rivaroxaban Sales in Volume, by Application (2018, 2022 & 2029)

6.4 Americas Rivaroxaban Market Facts & Figures by Country (2018, 2022 & 2029)

6.4.1 Americas Rivaroxaban Sales in Value by Country (2018, 2022 & 2029)

6.4.2 Americas Rivaroxaban Sales in Volume by Country (2018, 2022 & 2029)

6.4.3 United States

6.4.4 Canada

6.4.5 Mexico

6.4.6 Brazil

7 EMEA

7.1 EMEA Rivaroxaban Market Size YoY Growth 2018-2029

7.2 EMEA Rivaroxaban Sales in Volume, by Type (2018, 2022 & 2029)

7.3 EMEA Rivaroxaban Sales in Volume, by Application (2018, 2022 & 2029)

7.4 EMEA Rivaroxaban Market Facts & Figures by Country (2018, 2022 & 2029)

7.4.1 EMEA Rivaroxaban Sales in Value by Country (2018, 2022 & 2029)

7.4.2 EMEA Rivaroxaban Sales in Volume by Country (2018, 2022 & 2029)

7.4.3 Europe

7.4.4 Middle East

7.4.5 Africa

8 China

8.1 China Rivaroxaban Market Size YoY Growth 2018-2029

8.2 China Rivaroxaban Sales in Volume, by Type (2018, 2022 & 2029)

8.3 China Rivaroxaban Sales in Volume, by Application (2018, 2022 & 2029)

9 APAC

9.1 APAC Rivaroxaban Market Size YoY Growth 2018-2029

9.2 APAC Rivaroxaban Sales in Volume, by Type (2018, 2022 & 2029)

9.3 APAC Rivaroxaban Sales in Volume, by Application (2018, 2022 & 2029)

9.4 APAC Rivaroxaban Market Facts & Figures by Region (2018, 2022 & 2029)

9.4.1 APAC Rivaroxaban Sales in Value by Region (2018, 2022 & 2029)

9.4.2 APAC Rivaroxaban Sales in Volume by Region (2018, 2022 & 2029)

9.4.3 Japan

9.4.4 South Korea

9.4.5 China Taiwan

9.4.6 Southeast Asia

9.4.7 India

10 Company Profiles

10.1 Bayer

10.1.1 Bayer Company Information

10.1.2 Bayer Description and Business Overview

10.1.3 Bayer Rivaroxaban Sales, Revenue and Gross Margin (2018-2023)

10.1.4 Bayer Rivaroxaban Products Offered

10.1.5 Bayer Recent Development

10.2 J&J

10.2.1 J&J Company Information

10.2.2 J&J Description and Business Overview

10.2.3 J&J Rivaroxaban Sales, Revenue and Gross Margin (2018-2023)

10.2.4 J&J Rivaroxaban Products Offered

10.2.5 J&J Recent Development

11 Industry Chain and Sales Channels Analysis

11.1 Rivaroxaban Industry Chain Analysis

11.2 Rivaroxaban Key Raw Materials

11.2.1 Key Raw Materials

11.2.2 Raw Materials Key Suppliers

11.3 Rivaroxaban Production Mode & Process

11.4 Rivaroxaban Sales and Marketing

11.4.1 Rivaroxaban Sales Channels

11.4.2 Rivaroxaban Distributors

11.5 Rivaroxaban Customers

12 Research Findings and Conclusion

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Bayer

Bayer AG

Janssen Pharmaceutica

J & J

List of Tables

Table 1. Rivaroxaban CAGR in Value, India VS Global, 2018 VS 2022 VS 2029

Table 2. Rivaroxaban Market Trends

Table 3. Rivaroxaban Market Drivers

Table 4. Rivaroxaban Market Challenges

Table 5. Rivaroxaban Market Restraints

Table 6. Global Rivaroxaban Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 7. India Rivaroxaban Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 8. Global Rivaroxaban Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 9. India Rivaroxaban Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 10. Global Key Manufacturers of Rivaroxaban, Ranked by Revenue (2022) & (US$ Million)

Table 11. Global Rivaroxaban Revenue by Manufacturer, (US$ Million), 2018-2023

Table 12. Global Rivaroxaban Revenue Share by Manufacturer, 2018-2023

Table 13. Global Rivaroxaban Sales by Manufacturer, (K Units), 2018-2023

Table 14. Global Rivaroxaban Sales Share by Manufacturer, 2018-2023

Table 15. Global Rivaroxaban Price by Manufacturer (2018-2023) & (USD/Unit)

Table 16. Global Rivaroxaban Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 17. Global Rivaroxaban by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rivaroxaban as of 2022)

Table 18. Global Key Manufacturers of Rivaroxaban, Manufacturing Base Distribution and Headquarters

Table 19. Global Key Manufacturers of Rivaroxaban, Product Offered and Application

Table 20. Global Key Manufacturers of Rivaroxaban, Date of Enter into This Industry

Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 22. Key Players of Rivaroxaban in India, Ranked by Revenue (2022) & (US$ million)

Table 23. India Rivaroxaban Revenue by Players, (US$ Million), (2018-2023)

Table 24. India Rivaroxaban Revenue Share by Players, (2018-2023)

Table 25. India Rivaroxaban Sales by Players, (K Units), (2018-2023)

Table 26. India Rivaroxaban Sales Share by Players, (2018-2023)

Table 27. Global Rivaroxaban Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 28. Global Rivaroxaban Sales in Volume by Region (2018-2023) & (K Units)

Table 29. Global Rivaroxaban Sales in Volume Forecast by Region (2024-2029) & (K Units)

Table 30. Global Rivaroxaban Sales in Value by Region (2018-2023) & (US$ Million)

Table 31. Global Rivaroxaban Sales in Value Forecast by Region (2024-2029) & (US$ Million)

Table 32. Americas Rivaroxaban Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 33. Americas Rivaroxaban Sales in Value by Country (2018-2023) & (US$ Million)

Table 34. Americas Rivaroxaban Sales in Value by Country (2024-2029) & (US$ Million)

Table 35. Americas Rivaroxaban Sales in Volume by Country (2018-2023) & (K Units)

Table 36. Americas Rivaroxaban Sales in Volume by Country (2024-2029) & (K Units)

Table 37. EMEA Rivaroxaban Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 38. EMEA Rivaroxaban Sales in Value by Country (2018-2023) & (US$ Million)

Table 39. EMEA Rivaroxaban Sales in Value by Country (2024-2029) & (US$ Million)

Table 40. EMEA Rivaroxaban Sales in Volume by Country (2018-2023) & (K Units)

Table 41. EMEA Rivaroxaban Sales in Volume by Country (2024-2029) & (K Units)

Table 42. APAC Rivaroxaban Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 43. APAC Rivaroxaban Sales in Value by Country (2018-2023) & (US$ Million)

Table 44. APAC Rivaroxaban Sales in Value by Country (2024-2029) & (US$ Million)

Table 45. APAC Rivaroxaban Sales in Volume by Country (2018-2023) & (K Units)

Table 46. APAC Rivaroxaban Sales in Volume by Country (2024-2029) & (K Units)

Table 47. Bayer Company Information

Table 48. Bayer Description and Business Overview

Table 49. Bayer Rivaroxaban Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 50. Bayer Rivaroxaban Product

Table 51. Bayer Recent Development

Table 52. J&J Company Information

Table 53. J&J Description and Business Overview

Table 54. J&J Rivaroxaban Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 55. J&J Rivaroxaban Product

Table 56. J&J Recent Development

Table 57. Key Raw Materials Lists

Table 58. Raw Materials Key Suppliers Lists

Table 59. Rivaroxaban Customers List

Table 60. Rivaroxaban Distributors List

Table 61. Research Programs/Design for This Report

Table 62. Key Data Information from Secondary Sources

Table 63. Key Data Information from Primary Sources

List of Figures

Figure 1. Rivaroxaban Product Picture

Figure 2. Global Rivaroxaban Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Rivaroxaban Market Size 2018-2029 (US$ Million)

Figure 4. Global Rivaroxaban Sales 2018-2029 (K Units)

Figure 5. India Rivaroxaban Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 6. India Rivaroxaban Market Size 2018-2029 (US$ Million)

Figure 7. India Rivaroxaban Sales 2018-2029 (K Units)

Figure 8. India Rivaroxaban Market Share in Global, in Value (US$ Million) 2018-2029

Figure 9. India Rivaroxaban Market Share in Global, in Volume (K Units) 2018-2029

Figure 10. Rivaroxaban Report Years Considered

Figure 11. Product Picture of 2.5 mg

Figure 12. Product Picture of 10 mg

Figure 13. Product Picture of 15 mg

Figure 14. Product Picture of 20 mg

Figure 15. Global Rivaroxaban Market Share by Type in 2022 & 2029

Figure 16. Global Rivaroxaban Sales in Value by Type (2018-2029) & (US$ Million)

Figure 17. Global Rivaroxaban Sales Market Share in Value by Type (2018-2029)

Figure 18. Global Rivaroxaban Sales by Type (2018-2029) & (K Units)

Figure 19. Global Rivaroxaban Sales Market Share in Volume by Type (2018-2029)

Figure 20. Global Rivaroxaban Price by Type (2018-2029) & (USD/Unit)

Figure 21. India Rivaroxaban Market Share by Type in 2022 & 2029

Figure 22. India Rivaroxaban Sales in Value by Type (2018-2029) & (US$ Million)

Figure 23. India Rivaroxaban Sales Market Share in Value by Type (2018-2029)

Figure 24. India Rivaroxaban Sales by Type (2018-2029) & (K Units)

Figure 25. India Rivaroxaban Sales Market Share in Volume by Type (2018-2029)

Figure 26. India Rivaroxaban Price by Type (2018-2029) & (USD/Unit)

Figure 27. Product Picture of Acute Coronary Syndrome (ACS)

Figure 28. Product Picture of Venous Thromboembolism (VTE)

Figure 29. Global Rivaroxaban Market Share by Application in 2022 & 2029

Figure 30. Global Rivaroxaban Sales in Value by Application (2018-2029) & (US$ Million)

Figure 31. Global Rivaroxaban Sales Market Share in Value by Application (2018-2029)

Figure 32. Global Rivaroxaban Sales by Application (2018-2029) & (K Units)

Figure 33. Global Rivaroxaban Sales Market Share in Volume by Application (2018-2029)

Figure 34. Global Rivaroxaban Price by Application (2018-2029) & (USD/Unit)

Figure 35. India Rivaroxaban Market Share by Application in 2022 & 2029

Figure 36. India Rivaroxaban Sales in Value by Application (2018-2029) & (US$ Million)

Figure 37. India Rivaroxaban Sales Market Share in Value by Application (2018-2029)

Figure 38. India Rivaroxaban Sales by Application (2018-2029) & (K Units)

Figure 39. India Rivaroxaban Sales Market Share in Volume by Application (2018-2029)

Figure 40. India Rivaroxaban Price by Application (2018-2029) & (USD/Unit)

Figure 41. Americas Rivaroxaban Sales in Volume Growth Rate 2018-2029 (K Units)

Figure 42. Americas Rivaroxaban Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 43. Americas Rivaroxaban Sales by Type (2018-2029) & (K Units)

Figure 44. Americas Rivaroxaban Sales Market Share in Volume by Type (2018-2029)

Figure 45. Americas Rivaroxaban Sales by Application (2018-2029) & (K Units)

Figure 46. Americas Rivaroxaban Sales Market Share in Volume by Application (2018-2029)

Figure 47. United States Rivaroxaban Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 48. Canada Rivaroxaban Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 49. Mexico Rivaroxaban Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 50. Brazil Rivaroxaban Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 51. EMEA Rivaroxaban Sales in Volume Growth Rate 2018-2029 (K Units)

Figure 52. EMEA Rivaroxaban Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 53. EMEA Rivaroxaban Sales by Type (2018-2029) & (K Units)

Figure 54. EMEA Rivaroxaban Sales Market Share in Volume by Type (2018-2029)

Figure 55. EMEA Rivaroxaban Sales by Application (2018-2029) & (K Units)

Figure 56. EMEA Rivaroxaban Sales Market Share in Volume by Application (2018-2029)

Figure 57. Europe Rivaroxaban Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 58. Middle East Rivaroxaban Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 59. Africa Rivaroxaban Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 60. China Rivaroxaban Sales in Volume Growth Rate 2018-2029 (K Units)

Figure 61. China Rivaroxaban Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 62. China Rivaroxaban Sales by Type (2018-2029) & (K Units)

Figure 63. China Rivaroxaban Sales Market Share in Volume by Type (2018-2029)

Figure 64. China Rivaroxaban Sales by Application (2018-2029) & (K Units)

Figure 65. China Rivaroxaban Sales Market Share in Volume by Application (2018-2029)

Figure 66. APAC Rivaroxaban Sales in Volume Growth Rate 2018-2029 (K Units)

Figure 67. APAC Rivaroxaban Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 68. APAC Rivaroxaban Sales by Type (2018-2029) & (K Units)

Figure 69. APAC Rivaroxaban Sales Market Share in Volume by Type (2018-2029)

Figure 70. APAC Rivaroxaban Sales by Application (2018-2029) & (K Units)

Figure 71. APAC Rivaroxaban Sales Market Share in Volume by Application (2018-2029)

Figure 72. Japan Rivaroxaban Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 73. South Korea Rivaroxaban Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 74. China Taiwan Rivaroxaban Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 75. Southeast Asia Rivaroxaban Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 76. India Rivaroxaban Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 77. Rivaroxaban Value Chain

Figure 78. Rivaroxaban Production Process

Figure 79. Channels of Distribution

Figure 80. Distributors Profiles

Figure 81. Bottom-up and Top-down Approaches for This Report

Figure 82. Data Triangulation

Figure 83. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions